Oxytocin antagonists: the next frontier in PE treatment
Yükleniyor...
Dosyalar
Tarih
2019
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Nature Research
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Premature ejaculation (PE) is the most common sexual dysfunction among men worldwide1 . The exact pathophysiology of PE is unknown, and current treatment modalities are inadequate . Dapoxetine, a short-acting selective serotonin reuptake inhibitor, is the only medication approved in Europe, but it has not yet been approved in the USA owing to its limited efficacy and several safety concerns . Thus, the search for an efficacious and safe treatment for PE is ongoing
Açıklama
Gül, Murat ( Aksaray, Yazar )
Anahtar Kelimeler
Cligosiban, Oxytocin, Pyridine Derivative, Triazole Derivative
Kaynak
Nature Reviews Urology
WoS Q Değeri
N/A
Scopus Q Değeri
Q1
Cilt
16
Sayı
12
